New York State Common Retirement Fund
HARP

New York State Common Retirement Fund’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

New York State Common Retirement Fund’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16
Closed – – 3527
2022
Q2 		$0 Sell
16
-562
-97% -$14.6K ﹤0.01% 3575
2022
Q1 		$29K Hold
578
– – ﹤0.01% 3257
2021
Q4 		$44K Sell
578
-3
-0.5% -$205 ﹤0.01% 3243
2021
Q3 		$46K Sell
581
-1,152
-66% -$116K ﹤0.01% 3255
2021
Q2 		$240K Buy
1,733
+681
+65% +$130K ﹤0.01% 2969
2021
Q1 		$220K Hold
1,052
– – ﹤0.01% 2800
2020
Q4 		$175K Hold
1,052
– – ﹤0.01% 2800
2020
Q3 		$179K Hold
1,052
– – ﹤0.01% 2695
2020
Q2 		$175K Buy
1,052
+560
+114% +$87.4K ﹤0.01% 2702
2020
Q1 		$57K Hold
492
– – ﹤0.01% 2951
2019
Q4 		$73K Hold
492
– – ﹤0.01% 3069
2019
Q3 		$67K Buy
492
+442
+884% +$62.1K ﹤0.01% 3119
2019
Q2 		$7K Buy
+50
New +$5.81K ﹤0.01% 3229

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PSC
Piper Sandler & Co Minneapolis, Minnesota $135M AUM 0.15% 1-Year Est. Return

New York State Common Retirement Fund's HARP Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q3 2022, closing a stake of 16 shares.

New York State Common Retirement Fund first reported a position in HARP in Q2 2019 and held it in 13 quarters. The position peaked at $240K in Q2 2021. 52 funds tracked by Wall St. Rank hold HARP as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 16 Harpoon Therapeutics, Inc. Common Stock shares in Q3 2022.
  • New York State Common Retirement Fund first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q2 2019 and held it in 13 quarters.
  • New York State Common Retirement Fund's Harpoon Therapeutics, Inc. Common Stock position peaked at $240K in Q2 2021.
  • 52 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.